Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.CCR-17-1423

PubMed Identifier: 28765326

Publication URI: http://europepmc.org/abstract/MED/28765326

Type: Journal Article/Review

Volume: 23

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 21

ISSN: 1078-0432